Scientific programme

Scientific programme

This Congress will showcase a plethora of relevant topics in the exciting field of Transfusion Medicine, from recruitment of blood donors to the actual donation process, biology of blood cells, preparation of blood components, transfusion-transmitted infectious diseases, immunohaematology patient blood management, adverse transfusion events, cellular therapies, and much more. Follow the ISBT announcements for more information about Workshops and special sessions, such as the Young Investigator Breakfast Sessions.

The Local Day will be organised by the Canadian Society of Transfusion Medicine and will focus on 200 years of Transfusion Medicine. More information about the programme of the Local Day, the ISBT Academy Day and the parallel sessions will be made available on this page. 

Simultaneous translation

On the Local Day (Saturday June 2) and Academy Day (Sunday June 3) simultaneous translation will be provided for French Canadians.

Click Here to Access the Congress Abstract Book

The congress abstract book is now available through the Wiley Online Library. You can freely access it online by clicking above, or access it via the congress app in due time. 

Young Investigators Breakfast

On Tuesday June 5, 2018 a breakfast is organized to informally bring Young Investigators (under 40 years old) together with Transfusion Medicine experts. The breakfast is held in room 401 in the Metro Convention Centre, Toronto. 

For more information click here

Transfusion Practitioners

On Monday June 4, 2018 a networking breakfast is organized to bring Transfusion Practitioners together to meet new colleagues and share ideas. The breakfast is held in room 401 in the Metro Convention Centre, Toronto.

For more information click here

Programme at a glance

Click here to view the scientific programme at a glance.


08.00 - 09.00Annual General Meeting of CSTM (Canadian Society of Transfusion Medicine)
09.00 - 10.15Ortho and Buchanan Awards and Lectures
10.15 - 10.30Break


11.00 - 12.00History of transfusion medicine in Canada
John Freedman
12.00 - 13.00Lunch


13.00 - 14.00The Canadian Blood Services turn 20: past, present and future
Graham Sher
14.00 - 14.30NAC/CCNMT update
Jennifer Fesser and Heather Hume
14.30 - 15.15From serology to genotyping and updates in testing
Gwen Clarke


15.15 - 16.00Introduction to the new products
Dana Devine
16.00 -16.45Novel approaches to teaching transfusion medicine
Yulia Lin
16.45 - 17.30Cellular therapy comes of age
Donna Wall


09.00 - 10.30Donors & Donation
09.00 - 09.30Apheresis donor eligibility criteria and selection in platelet, plasma and red cell collection 
C. Poole (South Africa)
09.30 - 10.00Short and longer-term risk of donor apheresis
M. Neyrinck (Belgium)
10.00 - 10.30Establishing an apheresis service in a resource-limited setting
B. Pheng (Cambodia)
09.00 - 10.30Education and Training
09.00 - 10.30Using simulation for training in clinical transfusion medicine
A. Petrosoniak & K. Pavenski (Canada)
10.30 - 11.00Coffee break

11.00 - 12.30Organisation and Quality
11.00 - 11.30Quality: what I know now that I wish I'd known then
M. Smith (New Zealand)
11.30 - 12.00Developing the quality team
L. Bust (South Africa)
12.00 - 12.30When things go badly: managing quality problems and complaints in transfusion medicine
T. Vuk (Croatia)
11.00 - 12.30 Transfusion-transmitted infectious diseases
11.00 - 11.15I TRY IT introduction
B. Custer (USA)
11.15 - 11.45I TRY IT research
A.El Riyami (Oman)
11.45 - 12.15I TRY IT research
A. Sepeti, Fiji
12.15 - 12.30Discussion
12.00 - 13.30Satellite Symposia
12.30 - 13.30Lunch Break


13.30 - 15.00Immunohaematology 
13.30 - 14.00What's new in the Kell and Gerbich blood group systems
P. Ligthart (Netherlands)
14.00 - 14.30And now there are 49: update on the MNS blood group system
C. Gassner (Switzerland)
14.30 - 15.00Kidd blood group system: only 3 antigens but what about the variants?
J. Hamilton (USA)
13.30 - 15.00Clinical transfusion practice
13.30 - 14.00Is it TACO, TRALI or something else? 
M. Looney (USA)
14.00 - 14.30None too SMAll: the global challenge of severe malarial anaemia and its transfusion support 
C. Cserti-Gazdewich (Canada) 
14.30 - 15.00What is ECMO, and why do we use it in critical illness? 
E. Fan (Canada)
15.00 - 15.30Break



15.30 - 17.00Immunohaematology 
15.30 - 16.00After 70 years, serological RhD determination is still challenging: DNA to the rescue
M. Pisacka (Czech Republic)
16.00 - 16.30Getting comfortable with Rh blood group system terminologies and databases
F. Werner (Germany)
16.30 - 17.00Decision-making in complex obstetric cases: How to end up with a healthy baby in HDFN
M. Delaney (USA)
15.30 - 17.00Cellular therapies and haemovigilance
15.30 - 16.00Microbial Safety of Cellular Therapeutics - Lessons from over ten years experience in microbial safety of platelet concentrates
M. Störmer (Germany) 
16.00 - 16.30Adverse outcomes and substances of human origin: Cases from the NOTIFY Library
E. Petrisli (Italy)
16.30 - 17.00Safety and surveillance issues in stem cell marketing
D. Sipp (Japan)
17.45 - 21.00Opening Ceremony & Welcome Reception

07.00 - 08.00Transfusion Practitioners
Networking Breakfast
08.30 - 10.00Immunobiology
08.30 - 09.00Drug induced haemolytic anaemia
D. Branch (Canada)
08.30 - 10.00Clinical 
08.30 - 09.00Challenges in PBM / Tools for PBM
P. Meybohm (Germany)
09.00 - 09.30Questioning the benefit of restrictive transfusion practice in older adults
G. Simon (Australia)
09.30 - 10.00The outcome of the Patient Blood Management Consensus Conference, Frankfurt April 2018
M.M. Mueller (Germany)
08.30 - 10.00Donors and Donation
The effect of iron on fetal and neonatal brain development
M. Georgieff (USA)
The effect of blood donation of women on the birth weight of their offspring
H. Ullum (Denmark)
08.30 - 10.00Cellular Therapies
08.30 - 09.00Cord blood expansion with novel small molecule 
G. Sauvageau (Canada)
09.00 - 09.30The use of cord blood in metabolic disorders and hypoxic brain injuries
J. Kurtzberg (USA)
08.30 - 10.00WP TTID
Overview of TTI WP mission, membership and activities
C. Seed (Australia)
Surveillance, risk assessment, and policy subgroup presentation
S. O'Brien (Canada)
Bacterial subgroup presentation
C. McDonald (UK)
Parasite subgroup presentation
E. Bloch (USA)
08.30 - 10.00WP IT
Electronic identity control, replacement identification and multiple transfusions made easy in the OR/ER
J. Georgsen (Denmark) 
Visibility and access to blood products via technology
L. Briggs (USA)
Practical consideration in implementing RFID for the blood supply
S. Lam (Singapore)
10.00 - 10.30Coffee break
10.30 - 12.00Plenary Session: Arthropod borne infections
10.30 - 12.00Insect disease vectors and their impact on human health
L. Harrington (USA)
10.30 - 12.00Malarial resistance
E. Leffler (UK)
10.30 - 12.00The immune role of platelets in malaria
B. McCorran (Australia)
12.00 - 13.30Satellite Symposia
12.00 - 14.00Lunch break
14.00 - 15.30Donors & donation
14.00 - 14.30Donor vasovagal reactions, how can we reduce them?
J. Castren (Finland)
14.00 - 15.30Blood products
14.00 - 14.30Novel platelet products
R. Cardigan (UK)
14.00 - 15.30Blood safety 
14.00 - 14.30Bacterial contamination - CBS experience
S. Ramirez Arcos (Canada)
14.00 - 15.30Management & Organisation
14.00 - 14.30Emergency preparedness for mass casualty events
H. Doughty (UK)
14.00 - 15.30Young investigators session
15.30 - 16.00Coffee break
16.00 - 17.30Blood products
16.00 - 17.30Pathogen inactivation technologies
D. Devine (Canada)
16.00 - 17.30Blood safety 
16.00 - 16.30The development and use of a Donor history questionnaire in Pakistan
I. Shabber (Pakistan)
16.30 - 17.00Addressing Transfusion Transmitted malaria in Kenya 
V. Magutu (Kenya)
16.00 - 17.30Clinical I
16.00 - 17.30Immunobiology 
16.00 - 17.30Transfusion Practitioners
16.00 - 16.30Disaster Planning: the role of the transfusion practitioner
C. Akers (Australia)
16.30 - 17.00The Transfusion Practitioner role in minimising blood wastage
L. Bielby (Australia)
17.00 - 17.30Is ONTraC on track? A fifteen year experience
A. Howell (Canada)
16.00 - 17.30Clinical II
16.00 - 16.30Transfusion of neonates: evidence & complications
A. Keir (Australia)
16.00 - 17.30WP Donors and donation
Complications of blood donation
C. Napoli (Italy)
Needle complications
M. Townsend (USA)
Apheresis complications
H. Vrielink (Netherlands)
08.30 - 09.30Jean Julliard Prize
08.30 - 09.30Introductory presentation
L. Fung (Australia)
09.00 - 09.30Jean Julliard Prize Lecture: Transfusion-related acute lung injury (TRALI): Identification of novel risk factors and potential therapies
R. Kapur (Sweden)
09.30 - 10.00Coffee break
10.00 - 11.30Presidential Award Session
10.00 - 10.15Opening
10.05 - 10.15Laudation
H. Reesink (Netherlands)
10.15 - 10.35Historical overview to prevent blood transmissible infectious agents
H. Alter (USA)
10.35 - 10.55Impact of hepatitis E virus infection on the safety of the blood supply
H. Zaaijer (Netherlands)
10.55 - 11.25Estimating risk and evaluating efficacy of risk reduction strategies 
M. Busch (USA)
11.25 - 11.30Award Ceremony
11.45 - 12.30ISBT General Assembly
Members of ISBT only
12.00 - 13.30Satellite Symposia
12.00 - 14.00Lunch break
14.00 - 15.30Donors & Donation
14.00 - 14.30MSM and blood donation 
S. Sauleda (Spain)
14.00 - 15.30Blood Products
14.00 - 14.30All about frozen platelets
M. Reade (Australia)
14.00 - 15.30Blood Safety 
14.00 - 14.30Indian experience of introducing a haemovigilance scheme
A. Bist (India)
14.00 - 15.30Immunobiology 
14.00 - 14.30The role of molecular genotyping - a new era
N. Gleadall (UK)
14.00 - 15.30Blood and product supply
14.00 - 14.30Towards a safe and sufficient blood supply in Africa
D. Kyeyune (Uganda)
14.00 - 15.30Tranfusion Practitioners
14.00 - 14.30ISBT Transfusion Practitioners survey feedback
A. Dhesi (UK)
14.00 - 15.30WP Blood supply management
Effective cold chain management
R. Tocchetti (Australia)

Outcome of survey on blood product wastage in developing countries
M. Yazer (USA) 
Challenges to emergency transfusion in developing/resource constrained countries
D. Kyeyune (Uganda)
15.30 - 16.00Coffee break
16.00 - 17.30Donor safety
16.00 - 16.30Donor health
E. Di Angelantonio (UK)
16.00 - 17.30Accreditation, Standards and Good Practice
16.00 - 16.30The challenges of implementing the European good practice guidelines for blood components
P. Mali (Lithuania)
16.30 - 17.00The African Society for Blood Transfusion Step-Wise Accreditation Programme: organisation, achievements and challenges
C. Tayou (Cameroon)
17.00 - 17.30ISBT Developing Country Award Presentation: Initiatives for improving blood transfusional services in a regional public tertiary healthcare institution in India.
N. Marwaha (India)
16.00 - 17.30Adverse Reactions
16.00 - 16.30ITP, from pathophysiology to treatment
M. Michel (France) 
16.00 - 17.30Clinical 
16.00 - 16.30Prevention & management of RBC Alloimmunisation in thalassemia
A.A. Pourfathollah (Iran)
16.00 - 17.30WP Rare donors/terminology/immunohematology
N. Thornton (UK)
Name that specificity: investigating and identifying complex and exotic Rh variants
T. Peyrard (France)
Making it all happen for patients with rare blood
V. Yahalom (Israel)
Cataloging blood group variation with the help of new tools
M.L. Olsson (Sweden)
16.00 - 17.30WP Cellular Therapy
The current status of human platelet lysate producation and manufacturing
T. Burnouf (Taiwan)
Platelet based clinical therapies: where are we now?
C. Cohn (USA)
Novel new platelet derived products: science, regulation and the evolving role of blood banks
M. Koh (UK/Singapore)
17.45 - 18.45Poster session


08.30 - 10.00Donors & Donation
08.30 - 09.00An overview of donor base models in Sub-Sahara Africa: challenges and successes
I. Bates (UK)
09.00 - 09.30Building a blood system: the view froum Saudi Arabia
M. Badawi (Saudi Arabia)
08.30 - 10.00Blood products
08.30 - 09.00Automated blood component production
J. Cid (Spain)
08.30 - 10.00Viruses
08.30 - 09.00Splenic Macrophage Subsets and Their Functioning during Blood-Borne Infections
R. D'Imperio Lima (Brazil)
08.30 - 10.00Immunobiology
08.30 - 10.00Clinical
08.30 - 09.00Lowering transfusion thresholds in haematopoetic stem cell transplantation
A. Tinmouth (Canada)

13.30 - 15.00
WP Clinical - paediatric subgroup
13.30 - 14.00Big Data applications in Pediatric Transfusion: size matters!
14.00 - 14.30Epidemiology: practice patterns and outcomes for children transfused for life threatening haemorrhage
P. Spinella (USA)
14.30 - 15.00Neonatal and paediatric haemovigilance
H. New (UK)
10.00 - 10.30Coffee break
10.30 - 12.00Plenary Session: Platelets
10.30 - 11.00In vitro production of platelets
J. Thon (USA)
11.00 - 11.30Novel roles for platelets in health and disease 
M. Rondina (USA)
11.30 - 12.00Prevention of HLA alloimmune refractoriness
K. Pavenski (Canada)
12.00 - 13.30Satellite Symposia
12.00 - 13.30Lunch break


13.30 - 15.00Donor Recruitment
13.30 - 14.00Strategies for Donor Recruitment in Ghana 
L. Asamoah Akuoko (Ghana)
13.30 - 15.00Clinical Audit and Education
13.30 - 14.00Improvind efficacy of audit and feedback to improve transfusion practice
S. Stanworth (UK)
13.30 - 15.00Products 
13.30 - 14.00The Effect of Sex and Age of the Donor on the Outcome of Transfusion Recipients
G. Edgren (Sweden)
14.00 - 14.30The Effect of Sex and Age of the Donor on the Outcome of Transfusion Recipients
R. Middelburg (Netherlands)
13.30 - 15.00Blood safety 
13.30 - 14.00Emerging infectious diseases
C. Erikstrup (Denmark)
13.30 - 15.00WP Platelet
13.30 - 13.55New discoveries in immune mediated thrombocytopenia: implications for diagnosis and therapy
H. Ni (Canada)
13.55 - 14.20Platelet serology for allo and autoantibodies: pivotal or just nice to have?
U. Sachs (Germany)
14.20 - 14.35Report on the 19th International Platelet Immunology workshop
L. Richard (Canada)
14.35 - 15.00Generation of HPA-matched platelet precursors from humans iPS cells using CRISPR-mediated genome engineering
P. Newman (USA)
15.00 - 15.30Coffee Break
15.30 - 17.30Plenary session - Transfusion Medicine past, present and future (Joint ISBT/AABB session) 
15.30 - 16.00Past
D. Starr (USA)
16.00 - 16.30Present
S. Dzik (USA)
16.30 - 17.00Future: Building a synthetic cell
P. Schwille (Germany)
17.00 - 17.30Surprise speaker
17.00 - 17.15Closing ceremony
20.00 - 23.00Congress Party / Banquet

Tuesday June 5, 2018 
7.00-8.15 hrs
Room 401, MTCC

The Young Investigators breakfast is a great opportunity for researchers, who are 40 years old or less to meet and talk to transfusion medicine experts, who will be available to discuss the challenges and joys of research and to give tips and suggestions. 

The breakfast will take place in an informal setting in room 401, a room with a view in the Metro Convention Centre, Toronto.

Applying for this event is no longer possible as the closing date was May 3, 2018. 

Please note that to attend this session, you need to have a good understanding of and be able to express yourself in English.

Monday June 4, 2018 
7.00-8.15 hrs
Room 401, MTCC

The Transfusion Practitioner networking breakfast is a great opportunity for transfusion practitioners, and those interested in developing the role, to connect and discuss common interests and establish links that can be further developed throughout the congress and beyond. 

The breakfast will take place in an informal setting in room 401, a room with a view in the Metro Convention Centre, Toronto. 

Applying for this event is no longer possible as the closing date was May 11, 2018.

** Each parallel session will comprise (an) invited speaker(s) and selected abstracts for oral presentation.